# Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19

> **NCT05385029** · — · COMPLETED · sponsor: **OMER B ABDELBASIT** · enrollment: 95 (actual)

## Conditions studied

- Thyroid Dysfunction
- Hypothyroidism
- Hyperthyroidism

## Interventions

- **DRUG:** Thyroxine

## Key facts

- **NCT ID:** NCT05385029
- **Lead sponsor:** OMER B ABDELBASIT
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-01
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2022-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05385029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05385029, "Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05385029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*